Is Crescent Capital Stock a Good Investment?
Crescent Capital Investment Advice | CCAP |
- Examine Crescent Capital's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Crescent Capital's leadership team and their track record. Good management can help Crescent Capital navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Asset Management & Custody Banks space and any emerging trends that could impact Crescent Capital's business and its evolving consumer preferences.
- Compare Crescent Capital's performance and market position to its competitors. Analyze how Crescent Capital is positioned in terms of product offerings, innovation, and market share.
- Check if Crescent Capital pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Crescent Capital's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Crescent Capital BDC stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Crescent Capital BDC is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Crescent Capital Stock
Researching Crescent Capital's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 13.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.91. Some equities with similar Price to Book (P/B) outperform the market in the long run. Crescent Capital BDC has Price/Earnings To Growth (PEG) ratio of 0.89. The entity last dividend was issued on the 28th of February 2025.
To determine if Crescent Capital is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Crescent Capital's research are outlined below:
| Crescent Capital BDC generated a negative expected return over the last 90 days | |
| About 13.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Crescent Capital BDC Inc Q4 2024 Earnings Call Highlights Navigating Challenges with ... |
Crescent Capital Quarterly Liabilities And Stockholders Equity |
|
Crescent Capital uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Crescent Capital BDC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Crescent Capital's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Crescent Capital's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Crescent Capital's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2020-05-12 | 2020-03-31 | 0.4 | 0.44 | 0.04 | 10 | ||
2023-02-22 | 2022-12-31 | 0.44 | 0.49 | 0.05 | 11 | ||
2020-11-04 | 2020-09-30 | 0.48 | 0.43 | -0.05 | 10 | ||
2023-05-10 | 2023-03-31 | 0.48 | 0.54 | 0.06 | 12 | ||
2021-11-10 | 2021-09-30 | 0.41 | 0.48 | 0.07 | 17 | ||
2021-08-11 | 2021-06-30 | 0.46 | 0.53 | 0.07 | 15 | ||
2024-11-06 | 2024-09-30 | 0.575 | 0.412 | -0.163 | 28 |
Crescent Capital Target Price Consensus
Crescent target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Crescent Capital's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 6 | Strong Buy |
Most Crescent analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Crescent stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Crescent Capital BDC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCrescent Capital Target Price Projection
Crescent Capital's current and average target prices are 18.04 and 19.67, respectively. The current price of Crescent Capital is the price at which Crescent Capital BDC is currently trading. On the other hand, Crescent Capital's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Crescent Capital Market Quote on 27th of February 2025
Target Price
Analyst Consensus On Crescent Capital Target Price
Crescent Capital Analyst Ratings
Crescent Capital's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Crescent Capital stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Crescent Capital's financials, market performance, and future outlook by experienced professionals. Crescent Capital's historical ratings below, therefore, can serve as a valuable tool for investors.Know Crescent Capital's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Crescent Capital is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Crescent Capital BDC backward and forwards among themselves. Crescent Capital's institutional investor refers to the entity that pools money to purchase Crescent Capital's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Denali Advisors Llc | 2024-12-31 | 183.8 K | Kovitz Investment Group Partners, Llc | 2024-12-31 | 177.3 K | Blackrock Inc | 2024-12-31 | 167.6 K | Hightower Advisors, Llc | 2024-12-31 | 136.7 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 119.1 K | Rockefeller Capital Management L.p. | 2024-12-31 | 118.6 K | Ubs Group Ag | 2024-12-31 | 117 K | Barclays Plc | 2024-12-31 | 116.1 K | Skandinaviska Enskilda Banken Ab | 2024-12-31 | 109.3 K | Texas County & District Retirement System | 2024-12-31 | 5 M | Fidelity National Title Group, Inc. | 2024-12-31 | 4.2 M |
Crescent Capital's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 671.92 M.Market Cap |
|
Crescent Capital's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.03 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.05 | 0.03 | |
| Return On Equity | 0.10 | 0.11 |
Determining Crescent Capital's profitability involves analyzing its financial statements and using various financial metrics to determine if Crescent Capital is a good buy. For example, gross profit margin measures Crescent Capital's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Crescent Capital's profitability and make more informed investment decisions.
Evaluate Crescent Capital's management efficiency
Crescent Capital BDC has return on total asset (ROA) of 0.0584 % which means that it generated a profit of $0.0584 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0993 %, meaning that it created $0.0993 on every $100 dollars invested by stockholders. Crescent Capital's management efficiency ratios could be used to measure how well Crescent Capital manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Crescent Capital's Return On Capital Employed is relatively stable compared to the past year. As of 02/27/2025, Return On Equity is likely to grow to 0.11, while Return On Tangible Assets are likely to drop 0.03. At this time, Crescent Capital's Total Current Liabilities is relatively stable compared to the past year. As of 02/27/2025, Liabilities And Stockholders Equity is likely to grow to about 2 B, while Non Current Liabilities Other is likely to drop slightly above 20.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 18.60 | 11.74 | |
| Tangible Book Value Per Share | 18.60 | 11.74 | |
| Enterprise Value Over EBITDA | 20.66 | 21.69 | |
| Price Book Value Ratio | 0.97 | 0.92 | |
| Enterprise Value Multiple | 20.66 | 21.69 | |
| Price Fair Value | 0.97 | 0.92 | |
| Enterprise Value | 1.3 B | 679.5 M |
Evaluating the management effectiveness of Crescent Capital allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Crescent Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Basic technical analysis of Crescent Stock
As of the 27th of February, Crescent Capital shows the risk adjusted performance of (0.01), and Mean Deviation of 0.703. Crescent Capital BDC technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Crescent Capital's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Crescent Capital insiders, such as employees or executives, is commonly permitted as long as it does not rely on Crescent Capital's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Crescent Capital insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Gerhard Lombard over three months ago Acquisition by Gerhard Lombard of 1500 shares of Crescent Capital at 18.275 subject to Rule 16b-3 | ||
Hawley George over six months ago Acquisition by Hawley George of 3022 shares of Crescent Capital subject to Rule 16b-3 | ||
Gerhard Lombard over six months ago Insider Trading | ||
Henry Chung over a year ago Disposition of tradable shares by Henry Chung of Crescent Capital subject to Rule 16b-3 | ||
Strandberg Steven F over a year ago Acquisition or disposition of Crescent Capital securities by Strandberg Steven F | ||
Strandberg Steven F over a year ago Acquisition or disposition of Crescent Capital securities by Strandberg Steven F |
Crescent Capital's Outstanding Corporate Bonds
Crescent Capital issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Crescent Capital BDC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Crescent bonds can be classified according to their maturity, which is the date when Crescent Capital BDC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Crescent Capital's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Crescent Capital's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 0.703 | |||
| Coefficient Of Variation | (6,153) | |||
| Standard Deviation | 1.04 | |||
| Variance | 1.08 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 7.11 | |||
| Value At Risk | (1.67) | |||
| Potential Upside | 1.05 | |||
| Skewness | (1.88) | |||
| Kurtosis | 6.78 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.1) | |||
| Mean Deviation | 0.703 | |||
| Coefficient Of Variation | (6,153) | |||
| Standard Deviation | 1.04 | |||
| Variance | 1.08 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.03) | |||
| Total Risk Alpha | (0.02) | |||
| Treynor Ratio | (0.11) | |||
| Maximum Drawdown | 7.11 | |||
| Value At Risk | (1.67) | |||
| Potential Upside | 1.05 | |||
| Skewness | (1.88) | |||
| Kurtosis | 6.78 |
Consider Crescent Capital's intraday indicators
Crescent Capital intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Crescent Capital stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Crescent Capital Corporate Filings
10K | 19th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify | |
F5 | 13th of February 2025 The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners | ViewVerify |
| 3rd of February 2025 Other Reports | ViewVerify |
Crescent Stock media impact
Far too much social signal, news, headlines, and media speculation about Crescent Capital that are available to investors today. That information is available publicly through Crescent media outlets and privately through word of mouth or via Crescent internal channels. However, regardless of the origin, that massive amount of Crescent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Crescent Capital news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Crescent Capital relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Crescent Capital's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Crescent Capital alpha.
Crescent Capital Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Crescent Capital can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Crescent Capital Corporate Management
| Daniel McMahon | Senior Relations | Profile | |
| Gerhard Lombard | Chief Officer | Profile | |
| Erik Barrios | Chief Officer | Profile | |
| Raymond Barrios | Managing Director | Profile | |
| George JD | Secretary Counsel | Profile | |
| Kirill Bouek | Controller | Profile |
Additional Tools for Crescent Stock Analysis
When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.